Company profile
Lunaphore Technologies SA
Lunaphore is disrupting tissue diagnostics field by fundamentally changing the time and resource driven nature of diagnostic assays on tumor sections. Just like the fast sequencing technologies have made genomics testing possible for everybody today, Lunaphore will make possible an order-of-magnitude higher number of tissue biomarker checks for each tumor.
Source: startup.ch
Highlights
Top 100 Swiss Startup Award 2019
Top 100 Swiss Startup Award 2018
Top 100 Swiss Startup Award 2017
Top 100 Swiss Startup Award 2016
Top 100 Swiss Startup Award 2015
Top 100 Swiss Startup Award 2014
Winner Venture Kick
Innosuisse Certificate
More news about Lunaphore Technologies SA
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
